VIETER

行情报告详情

首页 · 行情 · 医药健康与生命科学

颅颌面植入物市场主要参与者
医药健康与生命科学

颅颌面植入物市场

Craniomaxillofacial Implants Market

颅颌面植入物市场:2026年市场规模约为26亿美元,2031年市场规模约为37.6亿美元;预测期复合年增长率为7.68%;当前最大市场为北美;增长最快的市场为亚太地区。

浏览1
更新时间2026-08-20
内容类型市场研究报告

市场研究正文

规模、增长、细分、驱动因素与关键问题

内容模板:完整版

当前质量分 100.00,审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。

核心结论

颅颌面植入物市场:2026年市场规模约为26亿美元,2031年市场规模约为37.6亿美元;预测期复合年增长率为7.68%;当前最大市场为北美;增长最快的市场为亚太地区。

市场走势

结构化指标

指标年份数值性质
复合年增长率20317.68%机构预测
市场规模2026USD 2.6 billion机构预测
市场规模2031USD 3.76 billion机构预测

细分市场份额

orthognathic and dental surgery application · 202545.880%
hospitals end_user · 202662.460%
North America geography · 202539.560%
titanium and titanium alloys material · 202561.650%
plates and screws product_and_technique · 202545.760%

市场结构

维度细分项年份份额
applicationorthognathic and dental surgery202545.880%
end_userhospitals202662.460%
geographyNorth America202539.560%
materialtitanium and titanium alloys202561.650%
product_and_techniqueplates and screws202545.760%

关键结论

  • application 维度中,orthognathic and dental surgery 在 2025 年的公开份额为 45.88%。
  • end_user 维度中,hospitals 在 2026 年的公开份额为 62.46%。
  • geography 维度中,North America 在 2025 年的公开份额为 39.56%。
  • material 维度中,titanium and titanium alloys 在 2025 年的公开份额为 61.65%。
  • product_and_technique 维度中,plates and screws 在 2025 年的公开份额为 45.76%。

主要参与者

  1. B. Braun Melsungen AG
  2. Stryker Corporation
  3. Zimmer Biomet Holdings, Inc.
  4. Medtronic plc
  5. Johnson & Johnson

增长驱动因素

因素影响 CAGR地区相关性影响周期
Rising craniofacial trauma and reconstruction volumes+2.100%Global, concentrated in Asia-Pacific and North AmericaShort term (≤ 2 years)
Patient-specific and 3D-printed implant adoption+1.800%North America and Europe, with early uptake in the Asia-PacificMedium term (2-4 years)
Pediatric craniosynostosis and congenital deformity procedures+1.200%North America, Europe, Japan, and emerging Asia-Pacific, Middle East, and Africa marketsMedium term (2-4 years)
Expansion of orthognathic, maxillofacial, and aesthetic surgery+1.500%North America, Europe, South Korea, and ChinaMedium term (2-4 years)
Virtual surgical planning integration+0.900%North America and Europe, with early-stage adoption in the Asia-PacificLong term (≥ 4 years)
Resorbable and bioactive material use+1.400%Global, with the strongest uptake in pediatric centers in North America and EuropeMedium term (2-4 years)

市场制约因素

因素影响 CAGR地区相关性影响周期
High implant, planning, and procedure costs-1.800%Global, most acute in low- and middle-income countries and emerging Asia-Pacific marketsShort term (≤ 2 years)
Shortage of specialized craniomaxillofacial surgeons-1.200%Global, with a disproportionate effect in the Middle East and Africa, South America, and tier-2 Asia-Pacific citiesMedium term (2-4 years)
Regulatory and clinical validation complexity-0.800%Europe, North America, and high-SDI marketsMedium term (2-4 years)
Limited long-term evidence for advanced materials-0.700%Global, affecting payer coverage and hospital formulary inclusionLong term (≥ 4 years)

报告关注的关键问题

What is the projected value of craniomaxillofacial implants in 2031?

The sector is forecast to reach USD 3.76 billion by 2031, from USD 2.60 billion in 2026, at a 7.68% CAGR.

Which product category generates the most revenue?

Plates and screws led product revenue with a 45.76% share in 2025 because they are used across trauma, orthognathic surgery, and reconstruction.

Which material is expanding most quickly?

Bioabsorbable polymers are forecast to grow at a 10.89% CAGR through 2031, supported by their ability to avoid later hardware-removal procedures.

Why are patient-specific cranial implants gaining use?

They connect imaging, surgical planning, and implant design, and can support complex reconstruction with customized titanium or PEEK devices.

Which region holds the leading position?

North America accounted for 39.56% of revenue in 2025, supported by specialist care networks, reimbursement, and use of virtual surgical planning.

What limits wider adoption of advanced CMF implants?

High implant and planning costs, limited specialist availability, regulatory validation needs, and incomplete long-term evidence for newer materials remain key constraints.

市场概览

  • 增长最快市场:亚太地区
  • 最大市场:北美
  • 市场集中度:中等
Vieter 校准:机构预测不等于实际成交、订单、交付或出货。跨报告比较需要同时核对市场边界、基准年、币种及是否包含软件服务。本站不提供报告原文或全文译文。
查看来源:Mordor Intelligence